Comvita Ltd is a New Zealand based company. It is engaged in the development and marketing of natural health and wellbeing products. Its products include manuka honey, manuka honey extract, nutritional oils, royal jelly, olive leaf extract, and other products. The company's geographical segments include Greater China; ANZ; Rest of Asia; North America and EMEA. It derives a majority of its revenue from Greater China.
1974
577
LTM Revenue $115M
LTM EBITDA -$6.4M
$112M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
As of August 2025, Comvita reported last 12-month revenue of $115M and EBITDA of -$6.4M.
In the same period, Comvita generated $51.8M in LTM gross profit and -$48.0M in net income.
See Comvita valuation multiples based on analyst estimatesIn the most recent fiscal year, Comvita reported revenue of $120M and EBITDA of -$35.3M.
Comvita expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Comvita valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $115M | XXX | $120M | XXX | XXX | XXX |
Gross Profit | $51.8M | XXX | $66.4M | XXX | XXX | XXX |
Gross Margin | 45% | XXX | 55% | XXX | XXX | XXX |
EBITDA | -$6.4M | XXX | -$35.3M | XXX | XXX | XXX |
EBITDA Margin | -6% | XXX | -29% | XXX | XXX | XXX |
EBIT | -$38.9M | XXX | -$15.2M | XXX | XXX | XXX |
EBIT Margin | -34% | XXX | -13% | XXX | XXX | XXX |
Net Profit | -$48.0M | XXX | -$45.6M | XXX | XXX | XXX |
Net Margin | -42% | XXX | -38% | XXX | XXX | XXX |
Net Debt | XXX | XXX | $46.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Comvita has current market cap of NZD 107M (or $63.1M), and EV of NZD 190M (or $112M).
As of September 19, 2025, Comvita's stock price is NZD 2 (or $1).
See Comvita trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$112M | $63.1M | XXX | XXX | XXX | XXX | $-0.32 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialComvita's trades at 0.9x EV/Revenue multiple, and -15.6x EV/EBITDA.
See valuation multiples for Comvita and 15K+ public compsAs of September 19, 2025, Comvita has market cap of $63.1M and EV of $112M.
Equity research analysts estimate Comvita's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Comvita has a P/E ratio of -1.3x.
LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $63.1M | XXX | $63.1M | XXX | XXX | XXX |
EV (current) | $112M | XXX | $112M | XXX | XXX | XXX |
EV/Revenue | 1.0x | XXX | 0.9x | XXX | XXX | XXX |
EV/EBITDA | -17.5x | XXX | -15.6x | XXX | XXX | XXX |
EV/EBIT | -2.9x | XXX | -14.6x | XXX | XXX | XXX |
EV/Gross Profit | 2.2x | XXX | n/a | XXX | XXX | XXX |
P/E | -1.3x | XXX | -3.2x | XXX | XXX | XXX |
EV/FCF | 13.5x | XXX | -22.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialComvita's last 12 month revenue growth is 5%
Comvita's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Comvita's rule of 40 is 0% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Comvita's rule of X is 7% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Comvita and other 15K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 5% | XXX | -3% | XXX | XXX | XXX |
EBITDA Margin | -6% | XXX | -6% | XXX | XXX | XXX |
EBITDA Growth | -212% | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | 0% | XXX | 0% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 7% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 41% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 68% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
SynBiotic | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Comvita acquired XXX companies to date.
Last acquisition by Comvita was XXXXXXXX, XXXXX XXXXX XXXXXX . Comvita acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free TrialWhen was Comvita founded? | Comvita was founded in 1974. |
Where is Comvita headquartered? | Comvita is headquartered in New Zealand. |
How many employees does Comvita have? | As of today, Comvita has 577 employees. |
Is Comvita publicy listed? | Yes, Comvita is a public company listed on NZE. |
What is the stock symbol of Comvita? | Comvita trades under CVT ticker. |
When did Comvita go public? | Comvita went public in 2003. |
Who are competitors of Comvita? | Similar companies to Comvita include e.g. Acme United, EZZ Life Science, Lavipharm, Sarantis Group. |
What is the current market cap of Comvita? | Comvita's current market cap is $63.1M |
What is the current revenue of Comvita? | Comvita's last 12 months revenue is $115M. |
What is the current revenue growth of Comvita? | Comvita revenue growth (NTM/LTM) is 5%. |
What is the current EV/Revenue multiple of Comvita? | Current revenue multiple of Comvita is 1.0x. |
Is Comvita profitable? | Yes, Comvita is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Comvita? | Comvita's last 12 months EBITDA is -$6.4M. |
What is Comvita's EBITDA margin? | Comvita's last 12 months EBITDA margin is -6%. |
What is the current EV/EBITDA multiple of Comvita? | Current EBITDA multiple of Comvita is -17.5x. |
What is the current FCF of Comvita? | Comvita's last 12 months FCF is $8.3M. |
What is Comvita's FCF margin? | Comvita's last 12 months FCF margin is 7%. |
What is the current EV/FCF multiple of Comvita? | Current FCF multiple of Comvita is 13.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.